Abstract:BACKGROUND: Despite the considerable progress made in preventative methods, medication, and interventional therapies, it remains evident that cardiovascular events (CVEs) continue to be the primary cause of both death and morbidity among individuals diagnosed with coronary artery disease (CAD). OBJECTIVE: To compare the connection between lipoprotein a (Lp[a]), fibrinogen (Fib), and both parameters combined with all-cause mortality to detect their value as prognostic biomarkers. METHODS: This is a retrospective study. Patients diagnosed with CAD between January 2007 and December 2020 at the Guangdong Provincial People's Hospital (China) were involved in the study. 43,367 patients met the eligibility criteria. The Lp(a) and Fib levels were distributed into three tertile groups (low, medium, and high). All of the patients included in the study were followed up for all-cause mortality. Kaplan–Meier and Cox regression were performed to determine the relationship between Lp(a), Fib, and all-cause mortality. A concordance statistics model was developed to detect the impact of Fib and Lp(a) in terms of anticipating poor outcomes in patients with CAD. RESULTS: Throughout a median follow-up of 67.0 months, 6,883 (15.9%) patients died. Participants with high Lp(a) (above 27.60 mg/dL) levels had a significantly higher risk for all-cause mortality than individuals with low Lp(a) levels (below 11.13 mg/dL; adjusted hazard ratio [aHR] 1.219, 95% confidence interval [CI]: 1.141–1.304, p< 0.001). Similarly, patients with high Fib levels (above 4.32 g/L) had a significantly greater risk of developing all-cause mortality compared with those with reduced Fib levels (below 3.41 g/L; aHR 1.415, 95% CI: 1.323–1.514, p< 0.001). Patients with raised Lp(a) and Fib levels had the maximum risk for all-cause mortality (aHR 1.702; 95% CI: 1.558–1.859, p< 0.001). When considered together, Lp(a) and Fib caused a significant elevation of the concordance statistic by 0.009 (p< 0.05), suggesting a higher value for predicting mortality when combining the two indicators. CONCLUSION: High Lp(a) and Fib levels could be used as predictive biomarkers for all-cause mortality in individuals with CAD. The prediction accuracy for all-cause mortality improved after combining the two parameters.

Determination and Clinical Significance of Plasma Fibrinogen, Lipoprotein (a) and Platelet Parameters in Coronary Heart Disease

Predictive Value of Plasma Fibrinogen Levels in Patients Admitted for Acute Coronary Syndrome

Study Of The Correlation Between Blood Lipid Levels And The Severity Of Coronary Atherosclerosis In A Chinese Population Sample

Study on pathogenesis of plasma coagulation factors on coronary heart disease

Relation of Thrombomodulin, TFPI and Plasma Antioxidants in Healthy Individuals and Patients with Coronary Heart Disease.

Predictive Value of Homocysteine and Serum Ferritin for Coronary Heart Disease

Analysis on Correlation between Gensini Scores of Coronary Artery and Blood Fibrinogen and Glycosylated Hemoglobin

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

New Insights into the Association Between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: an Intravascular Optical Coherence Tomography Study

Fibrinogen is the One of Risk Factors of Coronary Heart Disease

Relationship between atherogenic index of plasma and fibrinogen and severity of coronary heart disease in patients underwent coronary angiography

The Correlationship of Plasma Lipoprotein-Associated Phospholipase A2, Hypersensitive C-reactive Protein and D-dimer in Coronary Artery Disease Patients

Association of Fibrinogen and Fibrinogen Gene Beta 148 and Beta 854 Polymorphisms with Coronary Heart Disease

Impact of lipoprotein(a) and fibrinogen on prognosis in patients with coronary artery disease: A retrospective cohort study

[The Relationship Between Hyperfibrinogenemia and Severity of Coronary Heart Disease].

Effects of Plasma Fibrinogen and Blood Lipids on Coronary Narrowing

Clinical significance of D-dimer and fibrinogen in early diagnosis of coronary heart disease

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease

A study in the correlation between vascular factors and plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease

The Predictive Value of Serum Advanced Fibrinogen and Uric Acid for Acute Coronary Event Risk